Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-09

Clinical Trial Update: Pilot Study to Investigate the Safety and Feasibility of AntiRetroviral Therapy for Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 pilot study evaluating the safety and feasibility of antiretroviral therapy for Alzheimer's disease (early onset) has completed, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Alzheimer Disease, Early Onset | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-08-09